Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9377 - 9384 of 12089 results
FDA Provides 11th Hour Delay of Product Tracing Requirements for Pharmacies
June 30, 2015| Blog| Viewpoint
Rocky Mountain High Part II: Colorado’s Highest Court Approves Employer’s Stance that Employee Toke is No Joke
June 29, 2015| Blog| Viewpoint
Federal Guidance on Independent Contractors on Its Way This Summer
June 29, 2015| Blog| Viewpoint
Supreme Court to Decide Two Cases Addressing Important Class and Collective Action Issues
June 29, 2015| Blog| Viewpoint
Jury Hits Employer With $2.2 Million Verdict For GINA Violations in Workplace Defecator Case
June 29, 2015| Blog| Viewpoint
DOJ Sues Four Michigan Hospitals for Secret Agreements Not to Compete
June 29, 2015| Alert| Viewpoint
E2’s “Revitalizing America's Middle Class in a Clean Energy Economy” Featuring Senator Elizabeth Warren
June 29, 2015| Blog| Viewpoint
Crowdfunding and IP in Health and Biotech Start-ups (Part 3): Potential Dangers
June 29, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|